Myriad Genetics (MYGN) PT Raised to $23 at Jefferies

August 9, 2017 8:40 AM

Jefferies raised its price target on Myriad Genetics (NASDAQ: MYGN) to $23.00 (from $21.00) while maintaining a Hold rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found